发明名称 |
NEW THERAPEUTIC STRATEGIES AGAINST BLOOD CANCER |
摘要 |
The present invention relates to the combination of at least one agent and a reduced calorie intake for use in the treatment of a blood cancer. In particular the agent is a CD20 inhibitor Bruton's tyrosine kinase inhibitor, a phosphoinositide 3-kinase inhibitor, a class I and/class II histone deacetylase inhibitor, a non-taxane replication inhibitor or a proteasome inhibitor. The combination is advantageous in that it sensitize cancer cells to said agent while it protects normal cells from toxicity induced by said agent. |
申请公布号 |
WO2017050849(A1) |
申请公布日期 |
2017.03.30 |
申请号 |
WO2016EP72467 |
申请日期 |
2016.09.21 |
申请人 |
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE |
发明人 |
LONGO, Valter;RAUCCI, Franca |
分类号 |
A61K45/06;A61K31/18;A61K31/33;A61K31/352;A61K31/404;A61K31/4965;A61K31/675;A61K31/69;A61K39/00;A61P35/00;A61P35/02 |
主分类号 |
A61K45/06 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|